Adicet Bio, Inc. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
Adicet Bio, Inc. (ACET) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 1.15 million shares as of 2021-02-28, per its 10-K filed 2022-03-15.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2022-03-15
- 2021-02-28: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.15M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2021-02-28 | 1.15M shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |